The market cap today is $135M.
In the real world when shares get canceled the market cap shouldn't change, so if you pull out the 12.6M from the O/S and left the same value we should be trading at $1.30.
More meaningfully though would be the fact that the float is being reduced by nearly 25%. This board must own at least 20% of that new float and most of us are holding for the big bucks. If institutions are buying in this area, who's going to sell at $3, $4 or $5? Not going to have many shares to go around when everything is made public.
Additionally, this cancellation makes way for the up-listing. The up-listing makes way for PRs, and in a few months we'll get to see the financials!
Did you see BYND the last week or two? They have sales of $88M and they are trading at $6Billion. That is a 68 revenue multiplier and a forward PE of 3,700 compared to TDOC's 10x multiplier. (Just for giggles, if CareClix makes only $10M revenue and had the BYND multiplier, you're looking at $6.8/share. If we had a small 5% net margin and traded at the 3700 PE like BYND we'd be trading at $90 lol, yes Nine-Zero.)
Per TDOC's metrics, CareClix is currently trading under the assumption its a $13M revenue company that is also not profitable. Under BYND's multiplier we're trading as a $2M revenue company.
Just think with a share cancellation, uplist, PRs, financials in the coming weeks to months along with a pretty large short position, we can see our valuations run to epic levels. Hype and FOMO are real, hold on to your shares!
One more tidbit. NUGS, had a 4M float when it made it's massive rally from .06 to $7.50, but it had an O/S of 277M, so it was valued at over $2B before coming back to reality. Ended up retesting that valuation despite having only $50k in revenue (yes thousands). We would be trading at $20 to have an equal $2B valuation. Just food for thought.
Market Data 
Markets 
AI
